Its discovery and characterization have led to the development of GLP-1 receptor agonists, a therapeutic This session provides a foundational overview of GLP-1 physiology and receptor pharmacology. The session also reviews currently approved GLP-1 receptor agonists, highlighting pharmacokinetic strategies In this Masterclass, she introduces the physiological and pharmacological foundations of GLP-1 receptor

In parallel, his earlier work on orphan receptor deorphanization used co-evolution analysis and machine Together, these projects represent a rare attempt to connect the molecular detail of receptor pharmacology with the population-scale reality of how those receptors behave in living patients. genetic variants across human populations Co-evolution and machine learning as a framework for orphan receptor Orphan receptors can be systematically approached through evolutionary logic Rather than screening compound

Overexpressing a receptor produces a big, convenient signal, but it distorts the pharmacology and drifts Along the way they discuss the receptors that simply refuse to yield an assay, from adhesion GPCRs to GLP-1 resurgence that returned GPCRs to the front of drug discovery De-orphanizing GPCRs, including receptors A single receptor can trigger a large, amplified cyclic AMP response, which makes overexpression assays For years the field's spotlight drifted to checkpoints and T-cell receptors.

doctoral dissertation was the first large-scale study of structure-activity relationships for adenosine receptors postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the first adenosine receptor He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor

and worked closely with Dr Birgitte Holst studying structural and mechanistic properties of ghrelin receptor associated with obesity and other metabolic diseases, including GPR10, Melanocortin 4, Serotonin 2C and TRH receptors cell-based in vitro technologies to study mechanistic properties of GPCRs and understanding the dynamics of receptor Jacek shared his fascination with the growth hormone secretion receptor and the melanocortin 4 receptor Yamina, in turn, talked about her work on melanocortin receptors and an upcoming collaboration with a

Filter & Explore Select Category Select Instructor Activation Mechanism of Metabotropic Glutamate Receptor 5 Kaavya Krishna Kumar May 19, 2023 Structural basis of the regulation of human chemokine receptor and HIV-1 co-receptor CCR5 Polina Isaikina July 21, 2023 Location bias of GRKs and Arrestins Sudarshan Rajagopal of functional selectivity Michel Bouvier March 15, 2024 Accurate Mechanistic Calculation of μ Opioid Receptor

his UC San Diego postdoc Krishna Sriram, he reread the literature on ACE inhibitors and angiotensin receptor His research career has centered on GPCR signaling — with particularly deep work on beta-adrenergic receptors , cyclic AMP regulation, and receptor biology across tissue systems. If the virus disrupts one arm of this receptor-peptide system, the therapeutic question stops being " Type II pneumocytes carry the highest beta-2 receptor density in the body.

sedative that prolongs exhalation and induces bradycardia—acting through alpha-2 adrenergic, not opioid, receptors investigates how fentanyl and xylazine shut down breathing through different mechanisms—work that blends receptor Listen now and see how one scientist is turning molecules into a mission, bridging the gap between receptor

Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors Sachdev pursued Ph.D. in the same lab where she investigated the molecular pharmacology of cannabinoid receptors

The conversation covers why GPCR targets are especially difficult to immunize against, how receptor family development The five-pillar approach to antibody characterization applied to notoriously difficult receptor Chemokine receptors like CXCR1 and CXCR2 share over 75% sequence identity - use the wrong peptide region LGR5 Became GeneTex's Reckoning with the GPCR Target Class LGR5 - a receptor critical to adult stem cell researcher approached the GeneTex booth and described his situation: he had knockout mice for the mu opioid receptor

Hannes Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology I spent 2 1/2 years in his lab and developed novel conformational sensors for these intriguing receptors

focuses on the mechanisms underlying biased signaling at GPCRs, specifically, the role of differential receptor He primarily studies the chemokine receptor CXCR3 as it has three naturally occurring ligands and thus

developing a powerful new computational tool for identifying ‘surrogate’ ligands (borrowed from other receptors this expertise to establish a research program that takes orphan GPCRs from ‘locked’, inaccessible receptors

Ph.D. from Department of Pharmacology, University of Washington (1992, mentor Charley Chavkin , sigma receptors Focus on study of drugs and toxins on GPCR (opioid, cannabinoid receptor) and ion channel (K, Ca, TRP

Since 2013, he has been elected Chair of the subcommittee for the Dopamine receptors of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification

San Francisco under the guidance of Professor Shaun Coughlin where she worked on the newly discovered protease-activated program is to gain a thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer progression. Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over

Matters Computational models are moving beyond interpretation into real-world prediction of ligand-receptor His team focuses on understanding how ligands modulate receptor function and how those insights can drive

Davide Calebiro | University of Birmingham The spatiotemporal organization of GPCR signalling Receptor The GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor

GPCR Biology <p class="font_8">Watch Now</p> Bryan Roth GPCR Molecular Glues: Biased Modulation at the Receptor–Transducer The GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor

years of experience in GPCR, primarily focused on drug discovery and developing new tools to study this receptor

Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes

The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors.

Julia studies the mechanisms of 'biased signaling' at GPCRs, with a specific focus on the chemokine receptor

The majority of my research is concentrated on rhodopsin family with a few works on metabotropic receptor

His group studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors

is currently focused on understanding the signal transduction pathways activated by beta-adrenergic receptors

In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow

Ray Stevens in 2013 solving several GPCR crystal structures, including that of the first serotonin receptor